1. Crane GE. Psychiatric side effects of iproniazid. Am J Psychiatry 1956; 112: 494–497.
2. Zeller AA, Barsky J. In vivo inhibition of liver and brain monoamine oxidase by l-isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med 1952; 81: 459–461.
3. Zeller EA, Barsky J, Fouts JR, Kirchheimer WF, van Orden LS. Influence of isonico- tinic acid hydrazide and l-isonicotinyl-2-isopropylhydrazide on bacterial and mammalian enzymes. Experientia 1952; 8: 349–350.
4. Youdim MBH, Finberg JMP. Monoamine oxidase inhibitors. In: Grahame-Smith DG, Cowen PE, editors. Psychopharmacology. Part 1, Preclinical Psychopharmacology. Amsterdam: Excerpta Medica, 1983: 37–51.
5. Murphy DL, Garrick NA, Aulakh CS, Cohen RM. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. J Clin Psychiatry 1984; 45: 37–43.